0001681171-16-000002.txt : 20160808 0001681171-16-000002.hdr.sgml : 20160808 20160808204805 ACCESSION NUMBER: 0001681171-16-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160727 FILED AS OF DATE: 20160808 DATE AS OF CHANGE: 20160808 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAVANAGH SARAH B CENTRAL INDEX KEY: 0001681171 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 161815816 MAIL ADDRESS: STREET 1: 400 SOMERSET CORPORATE BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2016-07-27 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001681171 KAVANAGH SARAH B 2150 ST. ELZEAR BLVD. LAVAL A8 H7L 4A8 QUEBEC, CANADA 1 0 0 0 Common Stock, no par value 2016-07-27 4 A 0 14458 0 A 14458 D Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. Prorated annual grant of restricted stock units equal to $339,640. Pricing is based on the closing price of registrant common stock on the date of grant. Robert Chai-Onn for Sarah B. Kavanagh 2016-08-08